Citations (124)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Elle Wadsworth, Lindsey A. Hines & David Hammond. (2022) Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States. Substance Abuse 43:1, pages 943-948.
Read now
Read now
Jan M Schilling, Chloe G Hughes, Mark S Wallace, Michelle Sexton, Miroslav Backonja & Tobias Moeller-Bertram. (2021) Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes. Journal of Pain Research 14, pages 1241-1250.
Read now
Read now
Namkee G. Choi & Diana M. DiNitto. (2021) Comparing older nonmedical and medical cannabis users: health-related characteristics, cannabis use patterns, and cannabis sources. The American Journal of Drug and Alcohol Abuse 47:5, pages 612-622.
Read now
Read now
Brianna Costales, Sascha van Boemmel-Wegmann, Almut Winterstein & Richard Segal. (2021) Clinical Conditions and Prescription Drug Utilization among Early Medical Marijuana Registrants in Florida. Journal of Psychoactive Drugs 53:3, pages 185-194.
Read now
Read now
Joao P. De Aquino, Mehmet Sofuoglu, Elina A. Stefanovics & Robert A. Rosenheck. (2020) Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: a nationwide longitudinal VA study. The American Journal of Drug and Alcohol Abuse 46:6, pages 812-822.
Read now
Read now
Assad Hayat & Brian J. Piper. (2020) Characteristics of Dispensary Patients that Limit Alcohol after Initiating Cannabis. Journal of Psychoactive Drugs 52:2, pages 145-152.
Read now
Read now
Brett C. Ginsburg. (2019) Strengths and limitations of two cannabis-impaired driving detection methods: a review of the literature. The American Journal of Drug and Alcohol Abuse 45:6, pages 610-622.
Read now
Read now
Marcus Bachhuber, Julia H. Arnsten & Gwen Wurm. (2019) Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary. Journal of Psychoactive Drugs 51:5, pages 400-404.
Read now
Read now
Harkiran K. Gill & Sean D. Young. (2019) Exploring cannabis use reasons and experiences among mobile cannabis delivery patients. Journal of Substance Use 24:1, pages 15-20.
Read now
Read now
Namkee G. Choi, Diana M. DiNitto & C. Nathan Marti. (2018) A longitudinal assessment of change in marijuana use with other substance use problems. The American Journal of Drug and Alcohol Abuse 44:6, pages 642-652.
Read now
Read now
Gabrielle Campbell, Wayne Hall & Suzanne Nielsen. (2018) What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review. International Review of Psychiatry 30:5, pages 91-106.
Read now
Read now
Jacob T. Borodovsky & Alan J. Budney. (2018) Cannabis regulatory science: risk–benefit considerations for mental disorders. International Review of Psychiatry 30:3, pages 183-202.
Read now
Read now
Articles from other publishers (112)
Jason Nunez, Jamie Corroon, Gary Vilke, Edward Castillo, Dunya N. Alfaraj & Christopher J. Coyne. (2023) Perceptions and Practices of Cannabis Use Among Emergency Department Patients. The Journal of Emergency Medicine 64:5, pages 543-554.
Crossref
Crossref
Ellen T. Kurtzman & Jessica Greene. (2023) How Are Patients Who Legally Use Medical Marijuana Treated When Hospitalized?. Policy, Politics, & Nursing Practice, pages 152715442311686.
Crossref
Crossref
H. Clarke & M. Fitzcharles. (2023) The evolving culture of medical cannabis in Canada for the management of chronic pain. Frontiers in Pharmacology 14.
Crossref
Crossref
Nirushi Kuhathasan, Pedro L. Ballester, Luciano Minuzzi, James MacKillop & Benicio N. Frey. (2023) Predictors of perceived symptom change with acute cannabis use for mental health conditions in a naturalistic sample: A machine learning approach. Comprehensive Psychiatry 122, pages 152377.
Crossref
Crossref
Shyam Raman, Johanna Catherine Maclean, W. David Bradford & Coleman Drake. (2023) Recreational cannabis and opioid distribution. Health Economics 32:4, pages 747-754.
Crossref
Crossref
Alessandro Rava & Viviana Trezza. (2023) Emerging Roles of Endocannabinoids as Key Lipid Mediators for a Successful Pregnancy. International Journal of Molecular Sciences 24:6, pages 5220.
Crossref
Crossref
Dianna Wolfe, Kim Corace, Claire Butler, Danielle Rice, Becky Skidmore, Yashila Patel, Premika Thayaparan, Alan Michaud, Candyce Hamel, Andra Smith, Gary Garber, Amy Porath, David Conn, Melanie Willows, Hanan Abramovici, Kednapa Thavorn, Salmaan Kanji & Brian Hutton. (2023) Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature. PLOS ONE 18:2, pages e0281826.
Crossref
Crossref
Peter Sunderland, David J Nutt & Anne Katrin Schlag. (2023) Medication sparing after medical cannabis initiation: A case study of a chronic pain patient in Project Twenty21. Drug Science, Policy and Law 9, pages 205032452311574.
Crossref
Crossref
Beatriz H. Carlini & Gillian L. Schauer. (2022) Cannabis-only use in the USA: prevalence, demographics, use patterns, and health indicators. Journal of Cannabis Research 4:1.
Crossref
Crossref
Alexis Holman, Daniel J. Kruger, Philippe Lucas, Kaye Ong, Rachel S. Bergmans & Kevin F. Boehnke. (2022) Healthcare provider and medical cannabis patient communication regarding referral and medication substitution: the Canadian context. Journal of Cannabis Research 4:1.
Crossref
Crossref
Maja Kalaba, Graham M. L. Eglit, Matthew T. Feldner, Patrizia D. Washer, Tracie Ernenwein, Alistair W. Vickery & Mark A. Ware. (2022) Longitudinal Relationship between the Introduction of Medicinal Cannabis and Polypharmacy: An Australian Real-World Evidence Study. International Journal of Clinical Practice 2022, pages 1-8.
Crossref
Crossref
Meenu MinhasStephanie E. Lunn. (2022)
Letter to the Editor:
The Need for Equitable Health Care Among Medical Cannabis Patients in Canada
. Cannabis and Cannabinoid Research 7:5, pages 719-721.
Crossref
Crossref
Ross Jason Bindler, Christy J. W. Watson, Abram J. Lyons, Lillian Skeiky, Jamie Lewis, Michael McDonell, Philip Lazarus & Marian Wilson. (2021) Drug-Drug Interaction Between Orally Administered Hydrocodone-Acetaminophen and Inhalation of Cannabis Smoke: A Case Report. Hospital Pharmacy 57:4, pages 518-525.
Crossref
Crossref
Matthew E. Hirschtritt, Lyndsay A. Avalos, Varada Sarovar, Kathryn K. Ridout, Nancy C. Goler, Deborah R. Ansley, Derek D. Satre & Kelly C. Young-Wolff. (2022) Association Between Prenatal Cannabis Use and Psychotropic Medication Use in Pregnant Patients With Depression and Anxiety. Journal of Addiction Medicine 16:4, pages e269-e273.
Crossref
Crossref
Anne Katrin Schlag, Michael Lynskey, Alan Fayaz, Alkyoni Athanasiou-Fragkouli, Brigitta Brandner, Barbara Haja, Elizabeth Iveson & David J. Nutt. (2022) Characteristics of People Seeking Prescribed Cannabinoids for the Treatment of Chronic Pain: Evidence From Project Twenty 21. Frontiers in Pain Research 3.
Crossref
Crossref
Luke A. Turnock. (2022) Exploring user narratives of self-medicated black market IPED use for therapeutic & wellbeing purposes. Performance Enhancement & Health 10:2, pages 100207.
Crossref
Crossref
Markus Köstenberger, Gerhard Nahler, Trevor M. Jones, Stefan Neuwersch & Rudolf Likar. (2021) The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians. Journal of Neuroimmune Pharmacology 17:1-2, pages 318-333.
Crossref
Crossref
Jonathan H. Aebischer, Nathan F. Dieckmann, Kim D. Jones & Amanda W. St John. (2022) Chronic Pain Clinical and Prescriptive Practices in the Cannabis Era. Pain Management Nursing 23:2, pages 109-121.
Crossref
Crossref
Mahmood AminiLari, Jason W. BusseJasmine Turna & James MacKillop. (2022) Declared Rationale for Cannabis Use Before and After Legalization for Nonmedical Use: A Longitudinal Study of Community Adults in Ontario. Cannabis and Cannabinoid Research.
Crossref
Crossref
Parisa Kavousi, Taylor Giamo, Gwen Arnold, Mateo Alliende, Elisabeth Huynh, Jaclyn Lea, Rachel Lucine, Alexandria Tillett Miller, Alana Webre, Aneka Yee, Adrianna Champagne‐Zamora & Keith Taylor. (2021) What do we know about opportunities and challenges for localities from Cannabis legalization?. Review of Policy Research 39:2, pages 143-169.
Crossref
Crossref
Yvonne Bonomo, Amanda Norman, Lisa Collins, Helen O’Neill, Peter Galettis, Jane Trinca, Nigel Strauss, Jennifer Martin & David Castle. (2021) Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study. Pain and Therapy 11:1, pages 171-189.
Crossref
Crossref
Shankar Tumati, Krista L. Lanctôt, RuoDing Wang, Abby Li, Andrew Davis & Nathan Herrmann. (2021) Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects. Drugs & Aging 39:2, pages 153-163.
Crossref
Crossref
Krzysztof Laudanski & Justin Wain. (2022) Considerations for Cannabinoids in Perioperative Care by Anesthesiologists. Journal of Clinical Medicine 11:3, pages 558.
Crossref
Crossref
Jørgen G. Bramness, Vidar Hjellvik, Audun Stubhaug & Svetlana Skurtveit. (2021) Possible opioid‐saving effect of cannabis‐based medicine using individual‐based data from the Norwegian Prescription Database. Basic & Clinical Pharmacology & Toxicology 130:1, pages 84-92.
Crossref
Crossref
Daniela Furrer, Edeltraut Kröger, Martine Marcotte, Nathalie Jauvin, Richard Bélanger, Mark Ware, Guillaume Foldes-Busque, Michèle Aubin, Pierre Pluye & Clermont E. Dionne. (2021) Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions. Journal of Cannabis Research 3:1.
Crossref
Crossref
Kevin F. Boehnke, Evangelos Litinas, Brianna Worthing, Lisa Conine & Daniel J. Kruger. (2021) Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution. Journal of Cannabis Research 3:1.
Crossref
Crossref
Erin M. Anderson Goodell, Courtney Nordeck, Patrick H. Finan, Ryan Vandrey, Kelly E. Dunn & Johannes Thrul. (2021) Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain. Internet Interventions 26, pages 100460.
Crossref
Crossref
Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark & Mark S Wallace. (2021) The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. JNCI Monographs 2021:58, pages 86-98.
Crossref
Crossref
James Siklos-Whillans, Alia Bacchus & Laurie A. Manwell. (2020) A Scoping Review of the Use of Cannabis and Its Extracts as Potential Harm Reduction Strategies: Insights from Preclinical and Clinical Research. International Journal of Mental Health and Addiction 19:5, pages 1527-1550.
Crossref
Crossref
Thomas Lebesmuehlbacher & Rhet A. Smith. (2021) The effect of medical cannabis laws on pharmaceutical marketing to physicians. Health Economics 30:10, pages 2409-2436.
Crossref
Crossref
Namkee G. Choi, Bryan Y. Choi, C. Nathan Marti & Diana M. DiNitto. (2021) Is cannabis use associated with prescription psychotropic and pain reliever medication and other substance use among individuals aged 50+ with mental illness?. Drug and Alcohol Dependence 225, pages 108842.
Crossref
Crossref
Danielle C. HergertCidney Robertson-BentaVeronik SicardDaniela SchwotzerKent HutchisonDan P. CoveyDavin K. QuinnJoseph R. SadekJacob McDonaldAndrew R. Mayer. (2021) Use of Medical Cannabis to Treat Traumatic Brain Injury. Journal of Neurotrauma 38:14, pages 1904-1917.
Crossref
Crossref
Sinikka L. Kvamme, Michael M. Pedersen, Kristine Rømer Thomsen & Birgitte Thylstrup. (2021) Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample. Harm Reduction Journal 18:1.
Crossref
Crossref
Atefeh Noori, Anna Miroshnychenko, Yaadwinder Shergill, Vahid Ashoorion, Yasir Rehman, Rachel J Couban, D Norman Buckley, Lehana Thabane, Mohit Bhandari, Gordon H Guyatt, Thomas Agoritsas & Jason W Busse. (2021) Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies. BMJ Open 11:7, pages e047717.
Crossref
Crossref
Kelly E. Dunn, Cecilia L. Bergeria, Andrew S. Huhn, Traci J. Speed, Chung Jung Mun, Ryan Vandrey & Claudia M. Campbell. (2021) Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model. Neuropsychopharmacology 46:8, pages 1451-1459.
Crossref
Crossref
Reilly R. Kayser, Meredith S. Senter, Rebecca Tobet, Marissa Raskin, Sapana Patel & H. Blair Simpson. (2021) Patterns of cannabis use among individuals with obsessive-compulsive disorder: Results from an internet survey. Journal of Obsessive-Compulsive and Related Disorders 30, pages 100664.
Crossref
Crossref
George Dranitsaris, Carlo DeAngelis, Blake Pearson, Laura McDermott & Bernd Pohlmann-Eden. (2021) Opioid Prescribing in Canada following the Legalization of Cannabis: A Clinical and Economic Time-Series Analysis. Applied Health Economics and Health Policy 19:4, pages 537-544.
Crossref
Crossref
Namkee G. Choi, Diana M. DiNitto & Kristina T. Phillips. (2021) Mental health treatment use among cannabis users aged 50+: Associations with cannabis use characteristics. Drug and Alcohol Dependence 223, pages 108705.
Crossref
Crossref
Shaina P. Cahill, Stephanie E. Lunn, Patrick Diaz & Jonathan E. Page. (2021) Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada. Frontiers in Public Health 9.
Crossref
Crossref
Joren Manz, Momoe Hyakutake & Erin Kelly. (2021) Calling for Openness to the Study of Cannabis Use in Chronic Pelvic Pain. Journal of Obstetrics and Gynaecology Canada 43:5, pages 611-613.
Crossref
Crossref
Jeremy Y. Ng, Kevin Gilotra, Sana Usman, Yaping Chang & Jason W. Busse. (2021) Attitudes toward medical cannabis among family physicians practising in Ontario, Canada: a qualitative research study. CMAJ Open 9:2, pages E342-E348.
Crossref
Crossref
Elena Cyrus, Makella S Coudray, Sandra Kiplagat, Yandra Mariano, Ines Noel, Jerome T Galea, Dexter Hadley, Jessy G Dévieux & Eric Wagner. (2021) A review investigating the relationship between cannabis use and adolescent cognitive functioning. Current Opinion in Psychology 38, pages 38-48.
Crossref
Crossref
Brandon R. McFadden & Trey Malone. (2021) Homegrown perceptions about the medical use and potential abuse of CBD and THC. Addictive Behaviors 115, pages 106799.
Crossref
Crossref
Bernard Le Foll. (2021) Opioid-sparing effects of cannabinoids: Myth or reality?. Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, pages 110065.
Crossref
Crossref
Laszlo L. Mechtler, Fran M. Gengo & Vincent H. Bargnes. (2021) Cannabis and Migraine: It’s Complicated. Current Pain and Headache Reports 25:3.
Crossref
Crossref
Reilly R. Kayser, Margaret Haney & Helen Blair Simpson. (2021) Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research. Frontiers in Psychiatry 12.
Crossref
Crossref
Jenna McAfee, Kevin F Boehnke, Stephanie M Moser, Chad M Brummett, Jennifer F Waljee & Erin E Bonar. (2021) Perioperative cannabis use: a longitudinal study of associated clinical characteristics and surgical outcomes. Regional Anesthesia & Pain Medicine 46:2, pages 137-144.
Crossref
Crossref
Kevin H. Yang, Christopher N. Kaufmann, Reva Nafsu, Ella T. Lifset, Khai Nguyen, Michelle Sexton, Benjamin H. Han, Arum Kim & Alison A. Moore. (2020) Cannabis: An Emerging Treatment for Common Symptoms in Older Adults. Journal of the American Geriatrics Society 69:1, pages 91-97.
Crossref
Crossref
Laurel P. Gibson, Leah N. Hitchcock, Angela D. Bryan & L. Cinnamon Bidwell. (2021) Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users. Complementary Therapies in Medicine 56, pages 102619.
Crossref
Crossref
Dorina V. Pinkhasova, Laura E. Jameson, Kendra D. Conrow, Michael P. Simeone, Allan Peter Davis, Thomas C. Wiegers, Carolyn J. Mattingly & Maxwell C.K. Leung. (2021) Regulatory status of pesticide residues in cannabis: Implications to medical use in neurological diseases. Current Research in Toxicology 2, pages 140-148.
Crossref
Crossref
Martha S. Rosenthal & R. Nathan Pipitone. (2020) Demographics, Perceptions, and Use of Medical Marijuana among Patients in Florida. Medical Cannabis and Cannabinoids 4:1, pages 13-20.
Crossref
Crossref
Kevin M Takakuwa & Dustin Sulak. (2020) A Survey on the Effect That Medical Cannabis Has on Prescription Opioid Medication Usage for the Treatment of Chronic Pain at Three Medical Cannabis Practice Sites. Cureus.
Crossref
Crossref
Emilia Lombardi, Joshua Gunter & Erin Tanner. (2020) Ohio physician attitudes toward medical Cannabis and Ohio’s medical marijuana program. Journal of Cannabis Research 2:1.
Crossref
Crossref
Babasola O. Okusanya, Ibitola O. Asaolu, John E. Ehiri, Linda Jepkoech Kimaru, Abidemi Okechukwu & Cecilia Rosales. (2020) Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review. Systematic Reviews 9:1.
Crossref
Crossref
Guohua Li & Stanford Chihuri. (2020) Is marijuana use associated with decreased use of prescription opioids? Toxicological findings from two US national samples of drivers. Substance Abuse Treatment, Prevention, and Policy 15:1.
Crossref
Crossref
Lara Sharpe, Justin Sinclair, Andrew Kramer, Michael de Manincor & Jerome Sarris. (2020) Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. Journal of Translational Medicine 18:1.
Crossref
Crossref
Jan Roberts. (2018) Medical Cannabis in Adult Mental Health Settings: Reconstructing One of the Most Maligned Medications in the United States. Clinical Social Work Journal 48:4, pages 412-420.
Crossref
Crossref
Julie Bobitt, Hyojung Kang, James Alton CrokerIIIIII, Laura Quintero Silva & Brian Kaskie. (2020) Use of cannabis and opioids for chronic pain by older adults: Distinguishing clinical and contextual influences. Drug and Alcohol Review 39:6, pages 753-762.
Crossref
Crossref
Kevin M. TakakuwaJeffrey Y. HergenratherFrances S. ShoferRaquel M. Schears. (2020) The Impact of Medical Cannabis on Intermittent and Chronic Opioid Users with Back Pain: How Cannabis Diminished Prescription Opioid Usage. Cannabis and Cannabinoid Research 5:3, pages 263-270.
Crossref
Crossref
Lauren R. Gorfinkel, Malki Stohl & Deborah Hasin. (2020) Association of Depression With Past-Month Cannabis Use Among US Adults Aged 20 to 59 Years, 2005 to 2016. JAMA Network Open 3:8, pages e2013802.
Crossref
Crossref
He Zhu & Li-Tzy Wu. (2020) Multiple drug use disorder diagnoses among drug-involved hospitalizations in the United States: Results from the 2016 National Inpatient Sample. Drug and Alcohol Dependence 213, pages 108113.
Crossref
Crossref
John Wolf, Ivan Urits, Vwaire Orhurhu, Jacquelin Peck, Mariam Salisu Orhurhu, Stephen Giacomazzi, Daniel Smoots, Charlie Piermarini, Laxmaiah Manchikanti, Alan D. Kaye, Rachel J. Kaye & Omar Viswanath. (2020) The Role of the Cannabinoid System in Pain Control: Basic and Clinical Implications. Current Pain and Headache Reports 24:7.
Crossref
Crossref
José C. Bouso, Daniel Jiménez‐Garrido, Genís Ona, Damian Woźnica, Rafael G. Santos, Jaime E.C. Hallak, Beatriz A. P. B. Paranhos, Felipe Almeida Mendes, Mauricio Yonamine, Miguel Á. Alcázar‐Córcoles & Magí Farré. (2020) Quality of Life, Mental Health, Personality and Patterns of Use in Self‐Medicated Cannabis Users with Chronic Diseases: A 12‐Month Longitudinal Study. Phytotherapy Research 34:7, pages 1670-1677.
Crossref
Crossref
Cecilia L Bergeria, Sean B Dolan, Matthew W Johnson, Claudia M Campbell & Kelly E Dunn. (2020) Evaluating the co-use of opioids and cannabis for pain among current users using hypothetical purchase tasks. Journal of Psychopharmacology 34:6, pages 654-662.
Crossref
Crossref
Howard Meng, Tianyang Dai, John G. Hanlon, James Downar, Shabbir M.H. Alibhai & Hance Clarke. (2020) Cannabis and cannabinoids in cancer pain management. Current Opinion in Supportive & Palliative Care 14:2, pages 87-93.
Crossref
Crossref
Cecilia L. Bergeria, Andrew S. Huhn & Kelly E. Dunn. (2020) The impact of naturalistic cannabis use on self-reported opioid withdrawal. Journal of Substance Abuse Treatment 113, pages 108005.
Crossref
Crossref
Jenna Valleriani, Rebecca Haines-Saah, Rielle Capler, Ricky Bluthenthal, M. Eugenia Socias, MJ Milloy, Thomas Kerr & Ryan McNeil. (2020) The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada. International Journal of Drug Policy 79, pages 102737.
Crossref
Crossref
Rhet A. Smith. (2019) THE EFFECTS OF MEDICAL MARIJUANA DISPENSARIES ON ADVERSE OPIOID OUTCOMES. Economic Inquiry 58:2, pages 569-588.
Crossref
Crossref
Megan Wildes, Teresa L. Bigand, Matthew E. Layton & Marian Wilson. (2020) Cannabis Use and Cognition in Adults Prescribed Opioids for Persistent Pain. Pain Management Nursing 21:1, pages 94-99.
Crossref
Crossref
Michael Van Ameringen, Jasmine Zhang, Beth Patterson & Jasmine Turna. (2020) The role of cannabis in treating anxiety. Current Opinion in Psychiatry 33:1, pages 1-7.
Crossref
Crossref
Benjamin J. McMichael, R. Lawrence Van Horn & W. Kip Viscusi. (2020) The impact of cannabis access laws on opioid prescribing. Journal of Health Economics 69, pages 102273.
Crossref
Crossref
Andy Wai Kan Yeung, Nikolay T. Tzvetkov, Nicolas Arkells, Luigi Milella, Adrian M. Stankiewicz, Łukasz Huminiecki, Olaf K. Horbanczuk & Atanas G. Atanasov. (2019) Molecular neuroscience at its “high”: bibliometric analysis of the most cited papers on endocannabinoid system, cannabis and cannabinoids. Journal of Cannabis Research 1:1.
Crossref
Crossref
Stanford Chihuri & Guohua Li. (2019) State marijuana laws and opioid overdose mortality. Injury Epidemiology 6:1.
Crossref
Crossref
Jade C. Yau, Shu Min Yu, William J. Panenka, Hadley Pearce, Kristina M. Gicas, Ric M. Procyshyn, Caroline MacCallum, William G. Honer & Alasdair M. Barr. (2019) Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments. BMC Psychiatry 19:1.
Crossref
Crossref
Jamie Corroon, Michelle Sexton & Ryan Bradley. (2019) Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey. BMC Family Practice 20:1.
Crossref
Crossref
Jamie L. Flexon, Lisa Stolzenberg & Stewart J. D'Alessio. (2019) The effect of cannabis laws on opioid use. International Journal of Drug Policy 74, pages 152-159.
Crossref
Crossref
Stephanie Lake, Zach Walsh, Thomas Kerr, Ziva D. Cooper, Jane Buxton, Evan Wood, Mark A. Ware & M. J. Milloy. (2019) Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. PLOS Medicine 16:11, pages e1002967.
Crossref
Crossref
Timothy E. Welty, Kevin E. Chapman, R. Edward FaughtJrJr & Robert J. Kotloski. (2019) American Epilepsy Society (AES): Written Comments to Norman E. “Ned” Sharpless, MD, Acting Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA), Department of Health and Human Services (HHS). Epilepsy Currents 19:6, pages 361-368.
Crossref
Crossref
Kevin F. Boehnke, J. Ryan Scott, Evangelos Litinas, Suzanne Sisley, Daniel J. Clauw, Jenna Goesling & David A. Williams. (2019) Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain. The Journal of Pain 20:11, pages 1362-1372.
Crossref
Crossref
Benedikt Fischer, Wayne Jones, Wayne Hall & Paul Kurdyak. (2019) Potential public health impacts of medical cannabis availability on opioid-related harms? Urgent but un-answered questions from Canada. International Journal of Drug Policy 73, pages 96-99.
Crossref
Crossref
Lisa R. Gerak, Peter F. Weed, David R. Maguire & Charles P. France. (2019) Effects of the synthetic cannabinoid receptor agonist JWH-018 on abuse-related effects of opioids in rhesus monkeys. Drug and Alcohol Dependence 202, pages 33-38.
Crossref
Crossref
Anuj Shah, Corey J. Hayes, Mrinmayee Lakkad & Bradley C. Martin. (2019) Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. Journal of General Internal Medicine 34:8, pages 1419-1426.
Crossref
Crossref
Kevin F. Boehnke, J. Ryan Scott, Evangelos Litinas, Suzanne Sisley, David A. Williams & Daniel J. Clauw. (2019) Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain. The Journal of Pain 20:7, pages 830-841.
Crossref
Crossref
Iftach Sagy, Lihi Bar-Lev Schleider, Mahmoud Abu-Shakra & Victor Novack. (2019) Safety and Efficacy of Medical Cannabis in Fibromyalgia. Journal of Clinical Medicine 8:6, pages 807.
Crossref
Crossref
Teresa Bigand, Cristina Lee Anderson, Mary Lee Roberts, Michele Rose Shaw & Marian Wilson. (2019) Benefits and adverse effects of cannabis use among adults with persistent pain. Nursing Outlook 67:3, pages 223-231.
Crossref
Crossref
Kathryn R. Tringale, Minh‐Phuong Huynh‐Le, Mia Salans, Deborah C. Marshall, Yuyan Shi & Jona A. Hattangadi‐Gluth. (2019) The role of cancer in marijuana and prescription opioid use in the United States: A population‐based analysis from 2005 to 2014. Cancer.
Crossref
Crossref
Sara P Khan, Thomas A Pickens & Daniel J Berlau. (2019) Perspectives on cannabis as a substitute for opioid analgesics. Pain Management 9:2, pages 191-203.
Crossref
Crossref
LaTrice Montgomery, Samantha Schiavon & Karen Cropsey. (2019) Factors Associated With Marijuana Use Among Treatment-seeking Adult Cigarette Smokers in the Criminal Justice Population. Journal of Addiction Medicine 13:2, pages 147-152.
Crossref
Crossref
Michelle SextonCarrie CuttlerLaurie K. Mischley. (2019) A Survey of Cannabis Acute Effects and Withdrawal Symptoms: Differential Responses Across User Types and Age. The Journal of Alternative and Complementary Medicine 25:3, pages 326-335.
Crossref
Crossref
Kevin F. BoehnkeSaurav GangopadhyayDaniel J. ClauwRebecca L. Haffajee. (2019) Qualifying Conditions Of Medical Cannabis License Holders In The United States. Health Affairs 38:2, pages 295-302.
Crossref
Crossref
Gabrielle Campbell, Emily Stockings & Suzanne Nielsen. (2019) Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. European Archives of Psychiatry and Clinical Neuroscience 269:1, pages 135-144.
Crossref
Crossref
Deepika Slawek, Senthil Raj Meenrajan, Marika Rose Alois, Paige Comstock Barker, Irene Mison Estores & Robert Cook. (2019) Medical Cannabis for the Primary Care Physician. Journal of Primary Care & Community Health 10, pages 215013271988483.
Crossref
Crossref
Michael J. Weaver. (2018) CORR Insights®: Has Self-reported Marijuana Use Changed in Patients Undergoing Total Joint Arthroplasty After the Legalization of Marijuana?. Clinical Orthopaedics & Related Research 477:1, pages 101-103.
Crossref
Crossref
Alexis C. Cooke, Kelly R. Knight & Christine Miaskowski. (2019) Patients’ and clinicians’ perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care. International Journal of Drug Policy 63, pages 23-28.
Crossref
Crossref
Abhiram R. Bhashyam, Marilyn Heng, Mitchel B. Harris, Mark S. Vrahas & Michael J. Weaver. (2018) Self-Reported Marijuana Use Is Associated with Increased Use of Prescription Opioids Following Traumatic Musculoskeletal Injury. Journal of Bone and Joint Surgery 100:24, pages 2095-2102.
Crossref
Crossref
Kamilla L. Venner, Dennis M. Donovan, Aimee N.C. Campbell, Dennis C. Wendt, Traci Rieckmann, Sandra M. Radin, Sandra L. Momper & Carmen L. Rosa. (2018) Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives. Addictive Behaviors 86, pages 111-117.
Crossref
Crossref
David J DiBenedetto, Valerie F Weed, Kelly M Wawrzyniak, Matthew Finkelman, Jenelle Paolini, Michael E Schatman, David Herrera & Ronald J Kulich. (2018) The Association Between Cannabis Use and Aberrant Behaviors During Chronic Opioid Therapy for Chronic Pain. Pain Medicine 19:10, pages 1997-2008.
Crossref
Crossref
David Caldicott. (2018) The Case For. Journal of Pharmacy Practice and Research 48:5, pages 475-477.
Crossref
Crossref
Marcus A. Bachhuber, Julia H. Arnsten, Chinazo O. Cunningham & Nancy Sohler. (2018) Does Medical Cannabis Use Increase or Decrease the Use of Opioid Analgesics and Other Prescription Drugs?. Journal of Addiction Medicine 12:4, pages 259-261.
Crossref
Crossref
Gabrielle Campbell, Wayne D Hall, Amy Peacock, Nicholas Lintzeris, Raimondo Bruno, Briony Larance, Suzanne Nielsen, Milton Cohen, Gary Chan, Richard P Mattick, Fiona Blyth, Marian Shanahan, Timothy Dobbins, Michael Farrell & Louisa Degenhardt. (2018) Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. The Lancet Public Health 3:7, pages e341-e350.
Crossref
Crossref
Eduardo R. Butelman, Angelo G. I. Maremmani, Silvia Bacciardi, Carina Y. Chen, Joel Correa da Rosa & Mary Jeanne Kreek. (2018) Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis. Frontiers in Psychiatry 9.
Crossref
Crossref
E. Alfonso Romero-Sandoval, Jack E. Fincham, Ashley L. Kolano, Brandi N. Sharpe & P. Abigail Alvarado-Vázquez. (2018) Cannabis for Chronic Pain: Challenges and Considerations. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38:6, pages 651-662.
Crossref
Crossref
Marcus A. BachhuberJulia H. ArnstenJoanna L. StarrelsChinazo O. Cunningham. (2018) Willingness to Participate in Longitudinal Research Among People with Chronic Pain Who Take Medical Cannabis: A Cross-Sectional Survey. Cannabis and Cannabinoid Research 3:1, pages 45-53.
Crossref
Crossref
Alexandra SiderisFahad KhanAlina BoltunovaGermaine CuffChristopher GhariboLisa V. Doan. (2018) New York Physicians' Perspectives and Knowledge of the State Medical Marijuana Program. Cannabis and Cannabinoid Research 3:1, pages 74-84.
Crossref
Crossref
Ran Abuhasira, Lihi Bar-Lev Schleider, Raphael Mechoulam & Victor Novack. (2018) Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly. European Journal of Internal Medicine 49, pages 44-50.
Crossref
Crossref
Marian Wilson, Hannah Y. Gogulski, Carrie Cuttler, Teresa L. Bigand, Oladunni Oluwoye, Celestina Barbosa-Leiker & MaryLee A. Roberts. (2018) Cannabis use moderates the relationship between pain and negative affect in adults with opioid use disorder. Addictive Behaviors 77, pages 225-231.
Crossref
Crossref
Mark A. Ware, Marc O. Martel, Roman Jovey, Mary E. Lynch & Joel Singer. (2017) A prospective observational study of problematic oral cannabinoid use. Psychopharmacology 235:2, pages 409-417.
Crossref
Crossref
Deborah S Hasin. (2017) US Epidemiology of Cannabis Use and Associated Problems. Neuropsychopharmacology 43:1, pages 195-212.
Crossref
Crossref
Marianne Beare Vyas, Virginia T. LeBaron & Aaron M. Gilson. (2018) The use of cannabis in response to the opioid crisis: A review of the literature. Nursing Outlook 66:1, pages 56-65.
Crossref
Crossref
Philippe Lucas. (2017) Rationale for cannabis-based interventions in the opioid overdose crisis. Harm Reduction Journal 14:1.
Crossref
Crossref
Marion McNabb & D. Steven White. (2020) Creating Cannabis Citizen Scientists Using Open and Community-Based Research Methodologies to Understand Cannabis Consumers and Patients in Massachusetts and the United States. SSRN Electronic Journal.
Crossref
Crossref
Benjamin J. McMichael, Ray Van Horn & W. Kip Viscusi. (2018) The Impact of Cannabis Access Laws on Opioid Prescribing. SSRN Electronic Journal.
Crossref
Crossref